Clinical Trials Logo

Clinical Trial Summary

This is a pivotal study. The study will examine the safety and efficacy of autologous adipose-derived stromal vascular fraction (SVF) cells processed with the GID SVF-2 device for pain, function and stiffness in the knees of osteoarthritic subjects.


Clinical Trial Description

Osteoarthritis is the main form of arthritis and affects over 20 million people in the United States. In the knee it can cause severe pain, reduced functionality and increased stiffness thus, a treatment that would reduce pain, increase function and reduce stiffness would be of benefit to many people.

This study will collect and disassociate adipose tissue and inject the stromal vascular fraction into the knee of the same patient. The study is controlled, randomized and double-blinded with 2 SVF treatments (high and low dose) and a placebo control. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02726945
Study type Interventional
Source The GID Group
Contact
Status Completed
Phase N/A
Start date April 2016
Completion date October 1, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01620541 - Comparing Ankle Fusion to Ankle Replacement
Completed NCT01577563 - Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). N/A
Completed NCT02113410 - Effect of Chair Yoga on Elders With Osteoarthritis N/A
Terminated NCT04941729 - Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip System N/A
Active, not recruiting NCT04097379 - Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA Phase 2